Pulmonary sclerosing hemangioma mimicking bronchial malignancy: A case report

Pulmonary sclerosing hemangioma is a rare benign neoplasm of the lung and predominantly occurs in female patients. Commonly, it presents as asymptomatic solitary pulmonary nodule on chest radiograph. We report a case of pulmonary sclerosing hemangioma who presented with fever and chest x-ray and computed tomography revealed cavitary lesion and mediastinal lymphadenopathy . The chest imaging findings were mimicking bronchial carcinoma. On histopathology and immune-cyto-histochemistry, we found her as having pulomonary sclerosisng hemangioma.The patient is now on follow up without any progression of the disease for last two months. Birdem Med J 2019; 9(3): 251-253

Symptomatic pulmonary sclerosing hemangioma: a rare case of a solitary pulmonary nodule in a woman of advanced age

Background Pulmonary sclerosing hemangioma (PSH) is a rare tumor that usually develops in middle-aged Asian women. PSH has four histological types (hemorrhagic, sclerotic, solid, and papillary) and often grows slowly in a lower lobe of the lung. Preoperative misdiagnosis frequently occurs because of the absence of specific clinical manifestations and imaging findings. Few reports have described PSH in women of advanced age. Case presentation: A 75-year-old woman presented to our hospital in China with a 5-day history of productive cough and intermittent hemoptysis. Computed tomography indicated bronchiectasis and a large mass in the left inferior lobe of the lung. Treatment of the bronchiectasis provided no symptom relief. The hemoptysis resolved following left lower pulmonary lobectomy, and PSH was pathologically diagnosed following surgery. At the time of this writing (after 6 months of follow-up), the tumor had not recurred, no metastases had been detected, and close follow-up was ongoing. Conclusions Both bronchiectasis and PSH can cause hemoptysis. This case demonstrates that PSH should be included as a differential diagnosis of hemoptysis in women of advanced age. For patients with chronic hemoptysis, the diagnosis of PSH should be considered if the therapeutic effect of bronchiectasis is poor.